跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
dibromodulcitol
首页
药物
dibromodulcitol
dibromodulcitol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
CN 104797267 A
申请人: DEL MAR PHARMACEUTICALS
优先权: 2012
CN
US
3 件公开
COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIBROMODULCITOL
EP 3795145 A3
申请人: BROWN DENNIS M
优先权: 2011
EP
US
2 件公开
VETERINARY USE OF DIANHYDROGALACTITOL, DIACETYLDIANHYDROGALACTITOL, AND DIBROMODULCITOL TO TREAT MALIGNANCIES
US 2015099803 A1
申请人: DELMAR PHARMACEUTICALS
优先权: 2013
US
2 件公开
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas
US 11717505 B2
申请人: DEL MAR PHARMACEUTICALS BC LTD
优先权: 2018
US
药物
反馈